SEC EDGAR Filing Information

Form 10KSB/A -- Optional form for annual and transition reports of small business issuers [Section 13 or 15(d), not S-B Item 405] [amend]

Period of Report: 2007-12-31
Filing Date Changed: 2008-04-29
Documents: 5

SEC Accession No.
0000812796-08-000021
Filing date: 2008-04-29
Accepted: 2008-04-29 16:14:14

Table of submitted documents:

Seq	Type	Document	Size	Description
1	10KSB/A	dor10k2007.htm	614076	DOR 10 K 2007
2	EX-31.1	ceocert10k2007.htm	12761	CEO CERT
3	EX-31.2	cfocert10k2007.htm	12705	CFO CERT
4	EX-32.1	ceosox10k2007.htm	6622	CEO SOX CERT
5	EX-32.2	cfosox10k2007.htm	6593	CFO SOX CERT

		0000812796-08-000021.txt	654374	Complete submission text file

Filer Information:

DOR BIOPHARMA INC (Filer) (0000812796)
IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10KSB/A | Act: 34 | File No.: 000-16929 | Film No.: 08785657
SIC: 2834 Pharmaceutical Preparations

Assistant Director 1

Business Address
850 BEAR TAVERN ROAD
SUITE 201
EWING NJ 08628
609-538-8200

Mailing Address
850 BEAR TAVERN ROAD
SUITE 201
EWING NJ 08628